Yay! Science has just given cancer patients an awesome Christmas present in the form of a vaccine proven to shrink cancerous tumors in mice by up to 80 percent.
Although it has only been demonstrated to be effective against similar mouse versions of breast and pancreatic tumors, researchers believe it can work for other types as well, including colorectal and ovarian cancers and multiple myeloma.
This is a breakthrough in cancer research that has been decades in the making. Sandra Gendler, a professor at the Mayo Clinic which partnered with the University of Georgia to develop the vaccine, said:
"This is the first time that a vaccine has been developed that trains the immune system to distinguish and kill cancer cells based on their different sugar structures on proteins such as MUC1. We are especially excited about the fact that MUC1 was recently recognized by the National Cancer Institute as one of the three most important tumor proteins for vaccine development."
Scientists are looking forward to continued development of the breakthrough and hope to try the vaccine in humans within the next couple of years.
[Image via AP Images.]